Dataset Open Access
P. I. Koukos;
M. Réau;
A. M. J. J. Bonvin
<?xml version='1.0' encoding='UTF-8'?> <record xmlns="http://www.loc.gov/MARC21/slim"> <leader>00000nmm##2200000uu#4500</leader> <datafield tag="041" ind1=" " ind2=" "> <subfield code="a">eng</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">Docking</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">Virtual Screening</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">HADDOCK</subfield> </datafield> <datafield tag="653" ind1=" " ind2=" "> <subfield code="a">COVID-19</subfield> </datafield> <controlfield tag="005">20200706071934.0</controlfield> <controlfield tag="001">3929438</controlfield> <datafield tag="700" ind1=" " ind2=" "> <subfield code="u">Utrecht University</subfield> <subfield code="0">(orcid)0000-0002-3862-8990</subfield> <subfield code="a">M. Réau</subfield> </datafield> <datafield tag="700" ind1=" " ind2=" "> <subfield code="u">Utrecht University</subfield> <subfield code="0">(orcid)0000-0001-7369-1322</subfield> <subfield code="a">A. M. J. J. Bonvin</subfield> </datafield> <datafield tag="856" ind1="4" ind2=" "> <subfield code="s">10826687140</subfield> <subfield code="z">md5:66a0362049db0243632d4121bce43e39</subfield> <subfield code="u">https://zenodo.org/record/3929438/files/mpro_tanimoto.tar.xz</subfield> </datafield> <datafield tag="542" ind1=" " ind2=" "> <subfield code="l">open</subfield> </datafield> <datafield tag="260" ind1=" " ind2=" "> <subfield code="c">2020-07-03</subfield> </datafield> <datafield tag="909" ind1="C" ind2="O"> <subfield code="p">openaire_data</subfield> <subfield code="p">user-bioexcel</subfield> <subfield code="p">user-covid-19</subfield> <subfield code="p">user-covid19-structure-hub</subfield> <subfield code="p">user-zenodo</subfield> <subfield code="o">oai:zenodo.org:3929438</subfield> </datafield> <datafield tag="100" ind1=" " ind2=" "> <subfield code="u">Utrecht University</subfield> <subfield code="a">P. I. Koukos</subfield> </datafield> <datafield tag="245" ind1=" " ind2=" "> <subfield code="a">HADDOCK shape-based screening against the COVID-19 main protease (Mpro)</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">user-bioexcel</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">user-covid-19</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">user-covid19-structure-hub</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">user-zenodo</subfield> </datafield> <datafield tag="536" ind1=" " ind2=" "> <subfield code="c">823830</subfield> <subfield code="a">BioExcel-2 Centre of Excellence for Computational Biomolecular Research</subfield> </datafield> <datafield tag="536" ind1=" " ind2=" "> <subfield code="c">777536</subfield> <subfield code="a">Integrating and managing services for the European Open Science Cloud</subfield> </datafield> <datafield tag="540" ind1=" " ind2=" "> <subfield code="u">https://creativecommons.org/publicdomain/zero/1.0/legalcode</subfield> <subfield code="a">Creative Commons Zero v1.0 Universal</subfield> </datafield> <datafield tag="650" ind1="1" ind2="7"> <subfield code="a">cc-by</subfield> <subfield code="2">opendefinition.org</subfield> </datafield> <datafield tag="520" ind1=" " ind2=" "> <subfield code="a"><p>The novel coronavirus (SARS-CoV-2) that has emerged from Wuhan, China in December 2019 has spread to almost all countries in the world causing a dramatic number of deaths. The current absence of antiviral treatment against the SARS-CoV-2 urges the scientific community to accelerate the drug discovery research process.</p> <p>One way to identify potential treatments and to be able to administer it swiftly is to focus on drug repurposing studies, i.e. to investigate the SARS-CoV-2 antiviral potential of drugs that have already been approved for human use.</p> <p>Proteins that are crucial for the survival and replication of the virus are the most attractive targets for such studies. Here we have focused on the SARS-CoV-2 main protease (3CLpro) that plays an essential role in the virus replication process by screening ~2000 approved drugs (and 6 experimental ones) against this particular protein using a shape-based assay.</p> <p>This is one part of a multi-target screen emphasising the main protease (Mrpo), the RNA-dependent-RNA-polymerase (RdRp) and human ACE2. The other datasets can found at the following locations:</p> <ul> <li><a href="https://zenodo.org/record/3929446">Mpro: Pharmacophore-based assay</a></li> <li><a href="https://zenodo.org/record/3929463">ACE2</a></li> <li><a href="https://zenodo.org/record/3929449">RdRp</a></li> </ul> <p>More information about this screen along with interactive visualisations of the top compounds can be found on our website <a href="https://bonvinlab.org/covid/">bonvinlab.org</a>.</p></subfield> </datafield> <datafield tag="773" ind1=" " ind2=" "> <subfield code="n">doi</subfield> <subfield code="i">isVersionOf</subfield> <subfield code="a">10.5281/zenodo.3929437</subfield> </datafield> <datafield tag="024" ind1=" " ind2=" "> <subfield code="a">10.5281/zenodo.3929438</subfield> <subfield code="2">doi</subfield> </datafield> <datafield tag="980" ind1=" " ind2=" "> <subfield code="a">dataset</subfield> </datafield> </record>
All versions | This version | |
---|---|---|
Views | 442 | 442 |
Downloads | 17 | 17 |
Data volume | 184.1 GB | 184.1 GB |
Unique views | 409 | 409 |
Unique downloads | 16 | 16 |